Literature DB >> 29908585

Are actinic keratoses really squamous cell cancer? How do we know if they would become malignant?

Claudio Conforti1, Emanuela Beninati2, Caterina Dianzani2.   

Abstract

Actinic keratosis (AK) is a very common skin disease caused by chronic sun exposure. AKs have historically been characterized as being "precancerous" or "premalignant." It is true that these lesions do not possess metastatic potential, because they are confined to the epidermis, but it is not accurate to deem them "premalignant." AK qualifies as a malignant neoplasm, because it also fulfills criteria for malignancy in classic pathology, namely, the capability, or potential, to kill by either destruction of tissue locally or by metastasis widely. In this context, AK is considered now by many a carcinoma in situ and can persist or progress to invasive squamous cell carcinoma (iSCC), which rarely metastasizes. Through this controversy, which speaks to an issue we have been debating for at least a century, we should like to start a constructive debate to reach a unanimous conclusion considering the various theories and points of view in the literature.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29908585     DOI: 10.1016/j.clindermatol.2017.08.013

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  7 in total

Review 1.  Diagnostic Accuracy of Dermoscopy of Actinic Keratosis: A Systematic Review.

Authors:  Karla L Valdés-Morales; María Luisa Peralta-Pedrero; Fermín Jurado-Santa Cruz; Martha Alejandra Morales-Sánchez
Journal:  Dermatol Pract Concept       Date:  2020-10-26

2.  A Secure Framework toward IoMT-Assisted Data Collection, Modeling, and Classification for Intelligent Dermatology Healthcare Services.

Authors:  Md Khairul Islam; Chetna Kaushal; Md Al Amin; Abeer D Algarni; Nazik Alturki; Naglaa F Soliman; Romany F Mansour
Journal:  Contrast Media Mol Imaging       Date:  2022-06-29       Impact factor: 3.009

Review 3.  Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice.

Authors:  Nevena Skroza; Nicoletta Bernardini; Ilaria Proietti; Concetta Potenza
Journal:  Ther Clin Risk Manag       Date:  2018-10-04       Impact factor: 2.423

4.  Long-term efficacy of interventions for actinic keratosis: protocol for a systematic review and network meta-analysis.

Authors:  Theresa Steeb; Markus V Heppt; Lars Becker; Christoph Kohl; Lars E French; Carola Berking
Journal:  Syst Rev       Date:  2019-10-11

5.  Diagnostic Accuracy of Electrical Impedance Spectroscopy in Non-melanoma Skin Cancer.

Authors:  Esra Sarac; Andreas Meiwes; Thomas Eigentler; Stephan Forchhammer; Lukas Kofler; Hans-Martin Häfner; Claus Garbe
Journal:  Acta Derm Venereol       Date:  2020-11-23       Impact factor: 3.875

6.  Management of patients with melanoma and non-melanoma skin cancers in the coronavirus disease 2019 era.

Authors:  Claudio Conforti; Nicola di Meo; Roberta Giuffrida; Iris Zalaudek
Journal:  Chin Med J (Engl)       Date:  2020-09-05       Impact factor: 2.628

7.  Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis.

Authors:  Y Kim; E Jorgenson; M M Asgari
Journal:  Br J Dermatol       Date:  2020-05-10       Impact factor: 9.302

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.